David is head of the corporate practice of our Belgium office. He advises on public and private M&A and acts for clients on all kinds of transactional matters.
With over 15 years of extensive industry experience, David specialises in every aspect of corporate transactional work, such as public and private M&A, venture capital transactions, general corporate lending, public offerings and general company law. A significant proportion of David’s work focuses on the digital business, life sciences and biotech sectors.
He has advised a wide range of leading Belgian companies and foreign multinationals, with a particular emphasis on modern technology companies. Recent work highlights include advising TiGenix on its NASDAQ IPO, advising the group Onepoint on its public takeover bid on Vision IT Group and a series of financing and capital market transactions for leading Belgian biotech companies.
David joined Osborne Clarke as a Partner in 2013, having previously worked at a leading international law firm. He obtained his law degree from the KU Leuven (2001) and an LL.M at King’s College London (2003). He regularly publishes updates on company law in the leading Belgian legal journal TBH–RDC.
David has been consistently recommended in the legal directories for corporate M&A where the corporate team is described as “without hesitation: excellent” and David is praised for “excelling at creating efficient solutions to complex problems”.
Osborne Clarke berät Alpha Foods beim Verkauf an Vendis Capitals Portfoliounternehmen Sylphar, lesen Sie hier mehr